A Call to Action for the CDC: Don’t Treat Diabetes as One Disease
Earlier this month, the CDC published a statement that had a lot of people talking. The data reported the number of new cases of diabetes decreased from 2009 to 2014. What many of us have found so frustrating is that the CDC doesn’t distinguish between type 1 and type 2, and in fact, type 1 is on the rise. The Glu team worked with our Chief Medical Officer, Dr. Henry Anhalt, and Executive Director/Founder Dana Ball to respond in a statement of their own:
T1D Exchange, a nonprofit focused on driving better, faster research to improve care and speed development of new therapies for people and families living with type 1 diabetes, calls upon the Centers for Disease Control (CDC) to clarify its recent statement about a significant decrease in the incidence of new cases of diabetes from 2009-2014.
Strikingly absent from the CDC statement was the statistical breakdown by diabetes types. In particular, the report comingled data collected from people living with type 2 diabetes and people living with type 1 diabetes.
Comingling of the data, particularly from the leading national public health institute of the United States, perpetuates the myth that diabetes is one disease sharing a name, while the reality is that type 1 and type 2 diabetes are actually two different diseases in the diabetes family. Among key differences is that unlike type 2 diabetes, type 1 diabetes is not lifestyle-dependent; it is the result of relentless autoimmune destruction of the insulin-producing cells of the pancreas. Once insulin cells are destroyed, individuals spend their lifetime closely monitoring Continue reading